ProfileGDS4718 / 238636_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 21% 23% 83% 25% 23% 27% 24% 22% 23% 22% 16% 21% 22% 21% 27% 26% 18% 24% 21% 25% 19% 24% 18% 19% 23% 26% 19% 33% 15% 26% 28% 35% 27% 18% 24% 19% 26% 23% 25% 80% 21% 26% 33% 20% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1921521
GSM549102patient 115, normal, homogenized [OPG study]4.2898323
GSM549104patient 119, normal, homogenized [OPG study]8.2505983
GSM549108patient 138, normal, homogenized [OPG study]4.3633725
GSM549119patient 077, normal, homogenized [OPG study]4.2804923
GSM549133patient 032, cancer, homogenized [OPG study]4.3449527
GSM549139patient 042, cancer, homogenized [OPG study]4.277824
GSM549099patient 107, normal, homogenized [OPG study]4.2343522
GSM549109patient 139, normal, homogenized [OPG study]4.2956123
GSM549110patient 046, normal, homogenized [OPG study]4.2067422
GSM549114patient 063, normal, homogenized [OPG study]3.9533716
GSM549122patient 082, normal, homogenized [OPG study]4.2028421
GSM549134patient 033, cancer, homogenized [OPG study]4.2226222
GSM549136patient 036, cancer, homogenized [OPG study]4.1347321
GSM549140patient 044, cancer, homogenized [OPG study]4.3935927
GSM549111patient 047, normal, homogenized [OPG study]4.3667926
GSM549113patient 057, normal, homogenized [OPG study]4.0307818
GSM549132patient 031, cancer, homogenized [OPG study]4.2738924
GSM549137patient 038, cancer, homogenized [OPG study]4.1747721
GSM549142patient 047, cancer, homogenized [OPG study]4.456625
GSM549100patient 110, normal, homogenized [OPG study]4.1226819
GSM549107patient 135, normal, homogenized [OPG study]4.2791524
GSM549115patient 068, normal, homogenized [OPG study]4.0374218
GSM549116patient 072, normal, homogenized [OPG study]4.0838919
GSM549120patient 078, normal, homogenized [OPG study]4.2717823
GSM549131patient 030, cancer, homogenized [OPG study]4.3325626
GSM549118patient 074, normal, homogenized [OPG study]4.1223519
GSM549129patient 027, cancer, homogenized [OPG study]4.7006533
GSM549123patient 088, normal, homogenized [OPG study]3.9591515
GSM549124patient 006, cancer, homogenized [OPG study]4.4308526
GSM549126patient 015, cancer, homogenized [OPG study]4.4244428
GSM549128patient 025, cancer, homogenized [OPG study]4.7527735
GSM549103patient 117, normal, homogenized [OPG study]4.4539127
GSM549117patient 073, normal, homogenized [OPG study]4.0762118
GSM549138patient 041, cancer, homogenized [OPG study]4.2791524
GSM549141patient 045, cancer, homogenized [OPG study]4.042919
GSM549130patient 028, cancer, homogenized [OPG study]4.3824626
GSM549101patient 111, normal, homogenized [OPG study]4.2605523
GSM549105patient 128, normal, homogenized [OPG study]4.3420725
GSM549106patient 134, normal, homogenized [OPG study]8.0355380
GSM549112patient 048, normal, homogenized [OPG study]4.1653621
GSM549125patient 011, cancer, homogenized [OPG study]4.4040326
GSM549127patient 024, cancer, homogenized [OPG study]4.6365833
GSM549135patient 035, cancer, homogenized [OPG study]4.0927520